Heart/Cardiovascular Disease

Prospera Test Evaluation in Cardiac Transplant (ProTECT)

An Evaluation of the Safety and Effectiveness of the Conformal CLAAS System for Left Atrial Appendage Occlusion

Re-Evaluation of the Corvia Atrial Shunt Device in a Precision Medicine Trial to Determine Efficacy in Mildly Reduced or Preserved EF Heart Failure

RCTof FlowTriever vs anticoagulation alone in pulmonary embolism

A Phase 2, Double-blind, Randomized, Placebo controlled Study to Evaluate the Effects of Sotatercept versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) due to Heart Failure with Preserved Ejection Fraction (HFpEF)

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Evolut EXPAND TAVR II Pivotal Trial

Parallel-group, prospective, randomized, controlled phase III trial of home High flow Nasal Therapy (HFNT) via myAirvo 3 plus usual COPD medical care vs. usual COPD medical care

AbatacepT foR ImmUne checkpoint inhibitor associated Myocarditis (ATRIUM): A Phase 3, Investigator-Initiated, Randomized, Double- Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Compared to Placebo in Hospitalized Participants with Immune Checkpoint Inhibitor Associated Myocarditis

Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE)

Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for >65 Year-olds

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation after CABG

WVU02HSC24: Development and Feasibility of Comprehensive Occupational Physical Activity Measurement for Cardiovascular Health - Phase 2